Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. DCBO
DCBO logo

DCBO Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Docebo Inc (DCBO) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
17.280
1 Day change
3.35%
52 Week Range
33.700
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Docebo Inc (DCBO) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown strong financial growth in the latest quarter and hedge funds are significantly increasing their positions, the technical indicators are bearish, and the stock lacks any immediate positive momentum or signals from Intellectia Proprietary Trading Signals. Additionally, analysts have recently lowered their price targets, and the options data suggests a cautious sentiment. Given the user's impatience and preference for clear opportunities, it is better to hold off on investing in DCBO at this time.

Technical Analysis

The technical indicators for DCBO are bearish. The MACD histogram is below 0 and negatively contracting, indicating weak momentum. The RSI is neutral at 47.317, and the moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 16.088, with resistance at 17.316 and support at 14.86.

Options Data

Bearish
Open Interest Put-Call Ratio
Neutral
Option Volume Put-Call Ratio

The high open interest put-call ratio suggests bearish sentiment, while the option volume put-call ratio is neutral. Implied volatility is high at 130.57, with an IV percentile of 96.8, indicating significant uncertainty in the market.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
8
Buy
5

Positive Catalysts

  • Hedge funds are significantly increasing their positions, with a 1100% increase in buying activity over the last quarter.

  • Strong financial performance in Q4 2025, with revenue up 10.51% YoY, net income up 125.47% YoY, and EPS up 156.41% YoY.

Neutral/Negative Catalysts

  • Analysts have lowered price targets recently, citing headwinds from the AWS contract roll-off and Dayforce churn.

  • Bearish technical indicators and lack of strong trading signals.

  • No recent news or significant catalysts to drive immediate growth.

Financial Performance

In Q4 2025, Docebo reported strong financial growth: Revenue increased by 10.51% YoY to $63.037M, net income surged by 125.47% YoY to $26.853M, and EPS rose by 156.41% YoY to 1. However, gross margin slightly declined by -1.62% YoY to 78.52%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have recently lowered their price targets for DCBO. Stifel reduced the target to $28 from $34, Morgan Stanley to $26 from $28, and Scotiabank to $25 from $32. While the underlying business shows strength, analysts expect near-term challenges and rangebound trading.

Wall Street analysts forecast DCBO stock price to rise
9 Analyst Rating
Wall Street analysts forecast DCBO stock price to rise
8 Buy
1 Hold
0 Sell
Strong Buy
Current: 16.720
sliders
Low
28
Averages
34.13
High
40
Current: 16.720
sliders
Low
28
Averages
34.13
High
40
Stifel
Buy
downgrade
$34 -> $28
AI Analysis
2026-03-02
Reason
Stifel
Price Target
$34 -> $28
AI Analysis
2026-03-02
downgrade
Buy
Reason
Stifel lowered the firm's price target on Docebo to $28 from $34 and keeps a Buy rating on the shares. While acknowledging that Docebo faces compounding headwinds this year from the AWS contract roll-off and ongoing Dayforce churn, the analyst contends that the underlying business "appears much healthier than headline metrics reveal."
Morgan Stanley
Equal Weight
downgrade
$28 -> $26
2026-03-02
Reason
Morgan Stanley
Price Target
$28 -> $26
2026-03-02
downgrade
Equal Weight
Reason
Morgan Stanley lowered the firm's price target on Docebo to $26 from $28 and keeps an Equal Weight rating on the shares. On the positive side, the firm learned this was one of Docebo's strongest gross bookings quarters since 2021, however it still views Docebo as a "show-me story," the analyst tells investors following earnings.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for DCBO
Unlock Now

People Also Watch